Global mRNA Vaccines & Therapeutics Market Growth 2021-2026

  • receipt Report ID : 154501
  • calendar_today Published On: Feb, 2021
  • file_copy Pages: 130
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this latest study, the 2020 growth of mRNA Vaccines & Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Vaccines & Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the mRNA Vaccines & Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.

Infectious Disease Vaccines

Cancer Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.

Standardized Preselected

Prophylactic Vaccines

Individualized Shared Antigens

Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks

Therapeutic Vaccines

Individualized Neoantigens

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.

Moderna Therapeutics

CureVac

Translate Bio

BioNTech

Sangamo Therapeutics

Argos Therapeutics

In-Cell-Art

eTheRNA

Ethris

Tiba Biotechnology

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2016-2026

2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region

2.2 mRNA Vaccines & Therapeutics Segment by Type

2.2.1 Infectious Disease Vaccines

2.2.2 Cancer Vaccines

2.3 mRNA Vaccines & Therapeutics Sales by Type

2.3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)

2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2016-2021)

2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021)

2.4 mRNA Vaccines & Therapeutics Segment by Application

2.4.1 Standardized Preselected

2.4.2 Prophylactic Vaccines

2.4.3 Individualized Shared Antigens

2.4.4 Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks

2.4.5 Therapeutic Vaccines

2.4.6 Individualized Neoantigens

2.5 mRNA Vaccines & Therapeutics Sales by Application

2.5.1 Global mRNA Vaccines & Therapeutics Sale Market Share by Application (2016-2021)

2.5.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Application (2016-2021)

2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021)

3 Global mRNA Vaccines & Therapeutics by Company

3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Company

3.1.1 Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021)

3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021)

3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company

3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021)

3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021)

3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company

3.4 Global Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers mRNA Vaccines & Therapeutics Product Location Distribution

3.4.2 Players mRNA Vaccines & Therapeutics Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 mRNA Vaccines & Therapeutics by Region

4.1 Global mRNA Vaccines & Therapeutics by Region

4.1.1 Global mRNA Vaccines & Therapeutics Sales by Region

4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Region

4.2 Americas mRNA Vaccines & Therapeutics Sales Growth

4.3 APAC mRNA Vaccines & Therapeutics Sales Growth

4.4 Europe mRNA Vaccines & Therapeutics Sales Growth

4.5 Middle East & Africa mRNA Vaccines & Therapeutics Sales Growth

5 Americas

5.1 Americas mRNA Vaccines & Therapeutics Sales by Country

5.1.1 Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021)

5.1.2 Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)

5.2 Americas mRNA Vaccines & Therapeutics Sales by Type

5.3 Americas mRNA Vaccines & Therapeutics Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC mRNA Vaccines & Therapeutics Sales by Region

6.1.1 APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021)

6.1.2 APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021)

6.2 APAC mRNA Vaccines & Therapeutics Sales by Type

6.3 APAC mRNA Vaccines & Therapeutics Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe mRNA Vaccines & Therapeutics by Country

7.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021)

7.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)

7.2 Europe mRNA Vaccines & Therapeutics Sales by Type

7.3 Europe mRNA Vaccines & Therapeutics Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Country

8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021)

8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021)

8.2 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type

8.3 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 mRNA Vaccines & Therapeutics Distributors

10.3 mRNA Vaccines & Therapeutics Customer

11 Global mRNA Vaccines & Therapeutics Market Forecast

11.1 Global mRNA Vaccines & Therapeutics Forecast by Region

11.1.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2026)

11.2.2 Global mRNA Vaccines & Therapeutics Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global mRNA Vaccines & Therapeutics Forecast by Type

11.7 Global mRNA Vaccines & Therapeutics Forecast by Application

12 Key Players Analysis

12.1 Moderna Therapeutics

12.1.1 Moderna Therapeutics Moderna Therapeutics Company Information

12.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered

12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Moderna Therapeutics Main Business Overview

12.1.5 Moderna Therapeutics Latest Developments

12.2 CureVac

12.2.1 CureVac Company Information

12.2.2 CureVac mRNA Vaccines & Therapeutics Product Offered

12.2.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 CureVac Main Business Overview

12.2.5 CureVac Latest Developments

12.3 Translate Bio

12.3.1 Translate Bio Company Information

12.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Offered

12.3.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Translate Bio Main Business Overview

12.3.5 Translate Bio Latest Developments

12.4 BioNTech

12.4.1 BioNTech Company Information

12.4.2 BioNTech mRNA Vaccines & Therapeutics Product Offered

12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 BioNTech Main Business Overview

12.4.5 BioNTech Latest Developments

12.5 Sangamo Therapeutics

12.5.1 Sangamo Therapeutics Company Information

12.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered

12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Sangamo Therapeutics Main Business Overview

12.5.5 Sangamo Therapeutics Latest Developments

12.6 Argos Therapeutics

12.6.1 Argos Therapeutics Company Information

12.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered

12.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Argos Therapeutics Main Business Overview

12.6.5 Argos Therapeutics Latest Developments

12.7 In-Cell-Art

12.7.1 In-Cell-Art Company Information

12.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Offered

12.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 In-Cell-Art Main Business Overview

12.7.5 In-Cell-Art Latest Developments

12.8 eTheRNA

12.8.1 eTheRNA Company Information

12.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Offered

12.8.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 eTheRNA Main Business Overview

12.8.5 eTheRNA Latest Developments

12.9 Ethris

12.9.1 Ethris Company Information

12.9.2 Ethris mRNA Vaccines & Therapeutics Product Offered

12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Ethris Main Business Overview

12.9.5 Ethris Latest Developments

12.10 Tiba Biotechnology

12.10.1 Tiba Biotechnology Company Information

12.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered

12.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Tiba Biotechnology Main Business Overview

12.10.5 Tiba Biotechnology Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. mRNA Vaccines & Therapeutics Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Infectious Disease Vaccines

Table 3. Major Players of Cancer Vaccines

Table 4. Global mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)

Table 5. Global mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)

Table 6. Global mRNA Vaccines & Therapeutics Revenue by Type (2016-2021) & ($ million)

Table 7. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021)

Table 8. Global mRNA Vaccines & Therapeutics Sale Price by Type (2016-2021)

Table 9. Global mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)

Table 10. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)

Table 11. Global mRNA Vaccines & Therapeutics Value by Application (2016-2021)

Table 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2016-2021)

Table 13. Global mRNA Vaccines & Therapeutics Sale Price by Application (2016-2021)

Table 14. Global mRNA Vaccines & Therapeutics Sales by Company (2019-2021) & (M Doses)

Table 15. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2019-2021)

Table 16. Global mRNA Vaccines & Therapeutics Revenue by Company (2019-2021) ($ Millions)

Table 17. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2019-2021)

Table 18. Global mRNA Vaccines & Therapeutics Sale Price by Company (2019-2021)

Table 19. Key Manufacturers mRNA Vaccines & Therapeutics Producing Area Distribution and Sales Area

Table 20. Players mRNA Vaccines & Therapeutics Products Offered

Table 21. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 22. New Products and Potential Entrants

Table 23. Mergers & Acquisitions, Expansion

Table 24. Global mRNA Vaccines & Therapeutics Sales by Region (2016-2021) (M Doses)

Table 25. Global mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)

Table 26. Global mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions)

Table 27. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021)

Table 28. Americas mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)

Table 29. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)

Table 30. Americas mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions)

Table 31. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)

Table 32. Americas mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)

Table 33. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)

Table 34. Americas mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)

Table 35. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)

Table 36. APAC mRNA Vaccines & Therapeutics Sales by Region (2016-2021) & (M Doses)

Table 37. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region (2016-2021)

Table 38. APAC mRNA Vaccines & Therapeutics Revenue by Region (2016-2021) & ($ Millions)

Table 39. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Region (2016-2021)

Table 40. APAC mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)

Table 41. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)

Table 42. APAC mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)

Table 43. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)

Table 44. Europe mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)

Table 45. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)

Table 46. Europe mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions)

Table 47. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)

Table 48. Europe mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)

Table 49. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)

Table 50. Europe mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)

Table 51. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)

Table 52. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2016-2021) & (M Doses)

Table 53. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2016-2021)

Table 54. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2016-2021) & ($ Millions)

Table 55. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2016-2021)

Table 56. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Type (2016-2021) & (M Doses)

Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type (2016-2021)

Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Application (2016-2021) & (M Doses)

Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)

Table 60. Global mRNA Vaccines & Therapeutics Sales Forecast by Type (2021-2026) & (M Doses)

Table 61. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Type (2021-2026)

Table 62. Global mRNA Vaccines & Therapeutics Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 63. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Type (2021-2026)

Table 64. Global mRNA Vaccines & Therapeutics Sales Forecast by Application (2021-2026) & (M Doses)

Table 65. Global mRNA Vaccines & Therapeutics Sales Market Share Forecast by Application (2021-2026)

Table 66. Global mRNA Vaccines & Therapeutics Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 67. Global mRNA Vaccines & Therapeutics Revenue Market Share Forecast by Application (2021-2026)

Table 68. Moderna Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 69. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered

Table 70. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 71. Moderna Therapeutics Main Business

Table 72. Moderna Therapeutics Latest Developments

Table 73. CureVac Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 74. CureVac mRNA Vaccines & Therapeutics Product Offered

Table 75. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 76. CureVac Main Business

Table 77. CureVac Latest Developments

Table 78. Translate Bio Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 79. Translate Bio mRNA Vaccines & Therapeutics Product Offered

Table 80. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 81. Translate Bio Main Business

Table 82. Translate Bio Latest Developments

Table 83. BioNTech Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 84. BioNTech mRNA Vaccines & Therapeutics Product Offered

Table 85. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 86. BioNTech Main Business

Table 87. BioNTech Latest Developments

Table 88. Sangamo Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 89. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered

Table 90. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 91. Sangamo Therapeutics Main Business

Table 92. Sangamo Therapeutics Latest Developments

Table 93. Argos Therapeutics Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 94. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered

Table 95. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 96. Argos Therapeutics Main Business

Table 97. Argos Therapeutics Latest Developments

Table 98. In-Cell-Art Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 99. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered

Table 100. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 101. In-Cell-Art Main Business

Table 102. In-Cell-Art Latest Developments

Table 103. eTheRNA Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 104. eTheRNA mRNA Vaccines & Therapeutics Product Offered

Table 105. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 106. eTheRNA Main Business

Table 107. eTheRNA Latest Developments

Table 108. Ethris Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 109. Ethris mRNA Vaccines & Therapeutics Product Offered

Table 110. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 111. Ethris Main Business

Table 112. Ethris Latest Developments

Table 113. Tiba Biotechnology Basic Information, mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors

Table 114. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered

Table 115. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E)

Table 116. Tiba Biotechnology Main Business

Table 117. Tiba Biotechnology Latest Developments

List of Figures

Figure 1. Picture of mRNA Vaccines & Therapeutics

Figure 2. mRNA Vaccines & Therapeutics Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global mRNA Vaccines & Therapeutics Sales Growth Rate 2016-2026 (M Doses)

Figure 7. Global mRNA Vaccines & Therapeutics Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. mRNA Vaccines & Therapeutics Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Infectious Disease Vaccines

Figure 10. Product Picture of Cancer Vaccines

Figure 11. Global mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020

Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Type (2016-2021)

Figure 13. mRNA Vaccines & Therapeutics Consumed in Standardized Preselected

Figure 14. Global mRNA Vaccines & Therapeutics Market: Standardized Preselected (2016-2021) & (M Doses)

Figure 15. mRNA Vaccines & Therapeutics Consumed in Prophylactic Vaccines

Figure 16. Global mRNA Vaccines & Therapeutics Market: Prophylactic Vaccines (2016-2021) & (M Doses)

Figure 17. mRNA Vaccines & Therapeutics Consumed in Individualized Shared Antigens

Figure 18. Global mRNA Vaccines & Therapeutics Market: Individualized Shared Antigens (2016-2021) & (M Doses)

Figure 19. mRNA Vaccines & Therapeutics Consumed in Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks

Figure 20. Global mRNA Vaccines & Therapeutics Market: Synthetic Self-Amplifying Mrna Vaccines for Pandemic Outbreaks (2016-2021) & (M Doses)

Figure 21. mRNA Vaccines & Therapeutics Consumed in Therapeutic Vaccines

Figure 22. Global mRNA Vaccines & Therapeutics Market: Therapeutic Vaccines (2016-2021) & (M Doses)

Figure 23. mRNA Vaccines & Therapeutics Consumed in Individualized Neoantigens

Figure 24. Global mRNA Vaccines & Therapeutics Market: Individualized Neoantigens (2016-2021) & (M Doses)

Figure 25. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2016-2021)

Figure 26. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application in 2020

Figure 27. Global mRNA Vaccines & Therapeutics Revenue Market by Company in 2020 ($ Million)

Figure 28. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2020

Figure 29. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2016-2021)

Figure 30. Global mRNA Vaccines & Therapeutics Revenue Market Share by Region in 2020

Figure 31. Americas mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)

Figure 32. Americas mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)

Figure 33. APAC mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)

Figure 34. APAC mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)

Figure 35. Europe mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)

Figure 36. Europe mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)

Figure 37. Middle East & Africa mRNA Vaccines & Therapeutics Sales 2016-2021 (M Doses)

Figure 38. Middle East & Africa mRNA Vaccines & Therapeutics Revenue 2016-2021 ($ Millions)

Figure 39. Americas mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020

Figure 40. Americas mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020

Figure 41. Americas mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020

Figure 42. Americas mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020

Figure 43. United States mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 44. Canada mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 45. Mexico mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 46. Brazil mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 47. APAC mRNA Vaccines & Therapeutics Sales Market Share by Region in 2020

Figure 48. APAC mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2020

Figure 49. APAC mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020

Figure 50. APAC mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020

Figure 51. China mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 52. Japan mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 53. Korea mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 54. Southeast Asia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 55. India mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 56. Australia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 57. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020

Figure 58. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020

Figure 59. Europe mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020

Figure 60. Europe mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020

Figure 61. Germany mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 62. France mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 63. UK mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 64. Italy mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 65. Russia mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 66. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country in 2020

Figure 67. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2020

Figure 68. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Type in 2020

Figure 69. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Application in 2020

Figure 70. Egypt mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 71. South Africa mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 72. Israel mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 73. Turkey mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 74. GCC Country mRNA Vaccines & Therapeutics Revenue Growth 2016-2021 ($ Millions)

Figure 75. Channels of Distribution

Figure 76. Distributors Profiles